CAR T Cells: Second-Line Treatment Option for NHL? - NCI

Recent trial results suggest that CAR T cells may be superior to standard treatments for B-cell NHL that has not responded or has returned after treatment.

/images/jhop/2022/February/Review_CA

CAR T Cells: Second-Line Treatment Option for NHL? - NCI

Frontiers CAR T-Cell Therapy Predictive Response Markers in Diffuse Large B-Cell Lymphoma and Therapeutic Options After CART19 Failure

CAR T Cells: Engineering Immune Cells to Treat Cancer - NCI

CAR T-Cell therapy for the management of mantle cell lymphoma, Molecular Cancer

T-cell therapies for T-cell lymphoma - Cytotherapy

Prospects in the management of patients with follicular lymphoma beyond first-line therapy

CAR T Cells: Engineering Immune Cells to Treat Cancer - NCI

Prospects in the management of patients with follicular lymphoma beyond first-line therapy